This country profile provides an overview of Gambia’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
N/A
Blinding trachoma
0%
Intestinal worms
47%
Bilharzia
0%
River blindness
N/A
33k
people received treatment in Gambia in 2019
135k
people did not receive treatment in Gambia in 2019
Elephantiasis
Gambia does not require mass treatment for elephantiasis.
Blinding trachoma
Gambia claims to have eliminated blinding trachoma as a public health problem.
Intestinal worms
Treatment coverage decreased from 48% in 2018 to 47% in 2019.
Pre-sch and school-aged children needing treatment
71k
Pre-school and school-aged children receiving treatment
33k
Bilharzia
Treatment coverage decreased from 61% in 2018 to 0% in 2019.
School-aged children needing treatment
98k
School-aged children receiving treatment
Zero
River blindness
Gambia does not require mass treatment for river blindness.
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in the Gambia.